Sharon Kochan, Executive VP U.S. Generics at PERRIGO CO (PRGO), sold 3,934 shares at $90.00 ($351K) on 2011-08-23, disclosed to the SEC on 2011-08-25.
Seasonal sale ($351k) by Executive VP U.S. Generics — this insider has traded PRGO in August in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $88.00 | 1,434 | $126K | 35.9% |
| 2 | $90.00 | 2,500 | $225K | 64.1% |
| Total | $89.27 avg | 3,934 | $351K | 100% |
| Filing → |
| PRGO | SELL | 2016-03-04 | $373K | — | Filing → |
| PRGO | SELL | 2014-11-12 | $839K | — | Filing → |
| PRGO | SELL | 2013-11-19 | $69K | — | Filing → |